BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23846207)

  • 1. Long-term suppression of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
    Dunn JH; Weinberg A; Chan LK; Mandava N; Levi ME; Olson JL
    JAMA Ophthalmol; 2013 Jul; 131(7):958-60. PubMed ID: 23846207
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
    Levi ME; Mandava N; Chan LK; Weinberg A; Olson JL
    Transpl Infect Dis; 2006 Mar; 8(1):38-43. PubMed ID: 16623819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis.
    Rifkin LM; Minkus CL; Pursell K; Jumroendararasame C; Goldstein DA
    Ocul Immunol Inflamm; 2017 Feb; 25(1):93-96. PubMed ID: 26652481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient.
    Goldsmith PM; Husain MM; Carmichael A; Zhang H; Middleton SJ
    Transplantation; 2012 Apr; 93(7):e30-2. PubMed ID: 22450598
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent CMV retinitis in non HIV.
    Wiwanitkit V
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):147; author reply 149. PubMed ID: 20480176
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Tufail A; Moe AA; Miller MJ; Wagar EA; Bruckner DA; Holland GN
    Ophthalmology; 1999 Jan; 106(1):133-41. PubMed ID: 9917794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of leflunomide in the treatment of complex cytomegalovirus syndromes.
    Avery RK; Mossad SB; Poggio E; Lard M; Budev M; Bolwell B; Waldman WJ; Braun W; Mawhorter SD; Fatica R; Krishnamurthi V; Young JB; Shrestha R; Stephany B; Lurain N; Yen-Lieberman B
    Transplantation; 2010 Aug; 90(4):419-26. PubMed ID: 20683281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide use in renal transplantation.
    Leca N
    Curr Opin Organ Transplant; 2009 Aug; 14(4):370-4. PubMed ID: 19512928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus retinitis: pathogenesis and treatment options.
    Koevary SB
    Optometry; 2000 Sep; 71(9):591-7. PubMed ID: 11016249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir.
    Imai Y; Shum C; Martin DF; Kuppermann BD; Drew WL; Margolis TP
    J Infect Dis; 2004 Feb; 189(4):611-5. PubMed ID: 14767813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
    J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of BK viremia in a pediatric heart transplant recipient.
    Butts RJ; Uber WE; Savage AJ
    J Heart Lung Transplant; 2012 May; 31(5):552-3. PubMed ID: 22406086
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitis.
    Liu W; Shum C; Martin DF; Kuppermann BD; Hall AJ; Margolis TP
    J Infect Dis; 2000 Oct; 182(4):1234-8. PubMed ID: 10979924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Jacobson MA
    N Engl J Med; 1997 Jul; 337(2):105-14. PubMed ID: 9211681
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide for cytomegalovirus: bench to bedside.
    Chacko B; John GT
    Transpl Infect Dis; 2012 Apr; 14(2):111-20. PubMed ID: 22093814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.
    Seo SK; Regan A; Cihlar T; Lin DC; Boulad F; George D; Prasad VK; Kiehn TE; Polsky B
    Clin Infect Dis; 2001 Nov; 33(9):e105-8. PubMed ID: 11577375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of a ganciclovir-resistant human cytomegalovirus strain with a new UL97 mutation in an AIDS patient.
    Baldanti F; Simoncini L; Talarico CL; Sarasini A; Biron KK; Gerna G
    AIDS; 1998 May; 12(7):816-8. PubMed ID: 9619816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.